Horizon Therapeutics PLC (HZNP): Price and Financial Metrics
HZNP Price/Volume Stats
| Current price | $116.30 | 52-week high | $116.38 |
| Prev. close | $116.25 | 52-week low | $60.03 |
| Day low | $116.26 | Volume | 28,881,200 |
| Day high | $116.38 | Avg. volume | 2,498,525 |
| 50-day MA | $109.80 | Dividend yield | N/A |
| 200-day MA | $108.24 | Market Cap | 26.63B |
HZNP Stock Price Chart Interactive Chart >
Horizon Therapeutics PLC (HZNP) Company Bio
Horizon Therapeutics plc is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. In 2014 Horizon executed a tax inversion to move its legal headquarters to Ireland to avail of Ireland's low tax rates and beneficial corporate tax system. On May 2, 2019, shareholders of the company approved the change of the company's name to Horizon Therapeutics plc. (Source:Wikipedia)
HZNP Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 10.09% |
| 5-year | 268.62% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | 5.61% |
| 2021 | 47.31% |
| 2020 | 102.07% |
| 2019 | 85.26% |
Continue Researching HZNP
Want to do more research on Horizon Therapeutics Public Ltd Co's stock and its price? Try the links below:Horizon Therapeutics Public Ltd Co (HZNP) Stock Price | Nasdaq
Horizon Therapeutics Public Ltd Co (HZNP) Stock Quote, History and News - Yahoo Finance
Horizon Therapeutics Public Ltd Co (HZNP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...